Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 895

Results For "X"

9431 News Found

Lancet study confirms Johnson & Johnson Ebola vaccine safe
Drug Approval | September 16, 2021

Lancet study confirms Johnson & Johnson Ebola vaccine safe

Data show the vaccine regimen induced neutralising antibody responses in nearly all participating adults and children 21 days after the second dose. Adults receiving booster shots two years after the initial vaccination regimen showed strong immune responses


BLS empanelled to process Ayushman Bharat cards
Public Health | September 15, 2021

BLS empanelled to process Ayushman Bharat cards

The National Health Authority (NHA) aims to deliver 10 crore Ayushman Bharat cards in this financial year and extend free hospitalization benefits to 50 lakh people in a quarter


Lupin launch a generic version of pain reliever for osteoarthritis in the US
Drug Approval | September 15, 2021

Lupin launch a generic version of pain reliever for osteoarthritis in the US

Ibuprofen and Famotidine tablets (Duexise) had estimated annual sales of US $ 765 million in the US as if July 21


World’s first clinical trial for a rare headache disorder
Biotech | September 15, 2021

World’s first clinical trial for a rare headache disorder

The trial will evaluate the efficacy of psilocybin in Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA). The data is expected in early 2022


Fredun Pharma bags Rs 22 crore order from East African countries
News | September 15, 2021

Fredun Pharma bags Rs 22 crore order from East African countries

The order strengthens the company’s position in the East African market


Jharkhand to set up pharma park
Policy | September 15, 2021

Jharkhand to set up pharma park

The pharma park will be built at an estimated cost of Rs 34.94 crore and will be spread over 50 acres at Chanho close to Ranchi


Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment
News | September 15, 2021

Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment

These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients


Apollo Cancer Centres launch India’s first virtual duathlon
Hospitals | September 15, 2021

Apollo Cancer Centres launch India’s first virtual duathlon

Proceeds raised from the duathlon will go towards cancer treatment of children identified by the hospital


WPO and ECR release ‘Packaging Design for Recycling Guide’
Packaging | September 15, 2021

WPO and ECR release ‘Packaging Design for Recycling Guide’

The document is a global recommendation for circular packaging design. It will be updated and adapted to changes in the collection, sorting and recycling technology, as well as to future material development


NHS UK gives green light to a company to detect early-stage cancer by a simple blood test
News | September 14, 2021

NHS UK gives green light to a company to detect early-stage cancer by a simple blood test

Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025